1,397
Views
4
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

An inflammatory response with worsening of pleural effusion on treatment with erlotinib in non-small cell lung cancer

, , , , &
Pages 256-258 | Received 29 Mar 2006, Published online: 08 Jul 2009

Figures & data

Figure 1.  Computed Tomography of the thorax showing a right middle lobe mass with a moderate right pleural effusion (at diagnosis).

Figure 1.  Computed Tomography of the thorax showing a right middle lobe mass with a moderate right pleural effusion (at diagnosis).

Figure 2.  Computed Tomography of the thorax showing a large right pleural effusion with shift of the mediastinum to the left (14 days after treatment with erlotinib).

Figure 2.  Computed Tomography of the thorax showing a large right pleural effusion with shift of the mediastinum to the left (14 days after treatment with erlotinib).

Figure 3.  Computed Tomography of the thorax showing remnant of the right middle lobe mass and a right pleural effusion (4 months after treatment with erlotinib).

Figure 3.  Computed Tomography of the thorax showing remnant of the right middle lobe mass and a right pleural effusion (4 months after treatment with erlotinib).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.